Reid M Huber - Net Worth and Insider Trading
Reid M Huber Net Worth
The estimated net worth of Reid M Huber is at least $3 Million dollars as of 2024-11-13. Reid M Huber is the EVP, Chief Scientific Officer of Incyte Corp and owns about 35,183 shares of Incyte Corp (INCY) stock worth over $3 Million. Details can be seen in Reid M Huber's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Reid M Huber has not made any transactions after 2018-02-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Reid M Huber
Reid M Huber Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Reid M Huber owns 3 companies in total, including Bellicum Pharmaceuticals Inc (BLCM) , Incyte Corp (INCY) , and Tango Therapeutics Inc (TNGX) .
Click here to see the complete history of Reid M Huber’s form 4 insider trades.
Insider Ownership Summary of Reid M Huber
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BLCM | Bellicum Pharmaceuticals Inc | 2014-12-17 | director |
| INCY | Incyte Corp | 2018-02-21 | Exec VP & Chief Scientific Off |
| TNGX | Tango Therapeutics Inc | 2021-08-10 | director |
Reid M Huber Latest Holdings Summary
Reid M Huber currently owns a total of 1 stock. Reid M Huber owns 35,183 shares of Incyte Corp (INCY) as of February 21, 2018, with a value of $3 Million.
Latest Holdings of Reid M Huber
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INCY | Incyte Corp | 2018-02-21 | 35,183 | 80.59 | 2,835,398 |
Holding Weightings of Reid M Huber
Reid M Huber Form 4 Trading Tracker
According to the SEC Form 4 filings, Reid M Huber has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the sale of 1,958 shares on February 21, 2018, which brought Reid M Huber around $167,507.
Insider Trading History of Reid M Huber
- 1
Reid M Huber Trading Performance
Reid M Huber Ownership Network
Ownership Network List of Reid M Huber
Ownership Network Relation of Reid M Huber
Reid M Huber Owned Company Details
What does Bellicum Pharmaceuticals Inc do?
Who are the key executives at Bellicum Pharmaceuticals Inc?
Reid M Huber is the director of Bellicum Pharmaceuticals Inc. Other key executives at Bellicum Pharmaceuticals Inc include Chief Development Officer Charity Scripture , Principal Accounting Officer Charles S. Grass , and director & President and CEO Richard A. Fair .
Bellicum Pharmaceuticals Inc (BLCM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bellicum Pharmaceuticals Inc Insider Transactions
Reid M Huber Mailing Address
Above is the net worth, insider trading, and ownership report for Reid M Huber. You might contact Reid M Huber via mailing address: C/o Incyte Corporation, Experimental Stn, Route 141 & Henry Clay Road, Bldg. E336, Wilmington De 19880.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
